Pre-hospital Care With Intra-Nasal Ketamine for Transport (PRECINKT): A Pilot Study
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesize that intra-nasal ketamine, for analgesia of patients with
moderate to severe pain in an alpine setting, will provide a clinically significant reduction
in pain and provide an effective and feasible alternative to intravenous opioids.
The investigators wish to know:
1. Is our study protocol feasible to study INK in a mountain, prehospital care environment?
2. What estimate can be made of recruitment rates?
3. Does studying the use of INK interfere with or delay care at Whistler/Blackcomb?
4. Is intra-nasal ketamine an effective and safe method for controlling pain in our study
population and setting?
5. Does intranasal ketamine provide a clinically significant reduction in pain or do
patients require additional IV narcotics for extraction?
6. Are there any significant changes in vital signs after administration of intra-nasal
ketamine
7. Does the use of intra-nasal ketamine reduce time of patient extraction and transport in
the alpine pre-hospital setting?
8. Are there any long term sequelae of INK at one week?